Cafepharma Today

July 26 2024 - Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
PR NewsWire
Sunday, November 9, 2008 - 9:56am
tags:
Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing
PR - Indside
Sunday, November 9, 2008 - 9:55am
tags:
Biovail Declares Quarterly Dividend
PR - Inside
Sunday, November 9, 2008 - 9:53am
tags:
Biotech firms fear pricing pressure from Obama
San Francisco Chronicle, CA
Sunday, November 9, 2008 - 9:39am
tags:
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing
PR - Indside
Sunday, November 9, 2008 - 9:38am
tags:
SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R)
PR - Inside
Sunday, November 9, 2008 - 9:35am
tags:
Generic drug cos await US healthcare policies
Hindu Business Line, India
Sunday, November 9, 2008 - 9:32am
tags:
Merck Reaffirms Cardiovascular Research Commitment
Genetic Engineering News
Saturday, November 8, 2008 - 1:16pm
tags:
Zevalin sales spark big jump in Cell Therapeutics Q3 sales
bizjournals.com
Saturday, November 8, 2008 - 12:51pm
tags:
Dendreon’s Q3 loss grows
bizjournals.com
Saturday, November 8, 2008 - 12:50pm
tags:
Abbott's HUMIRA® (adalimumab) Data Shows Fistula Healing For Up To Three Years In Patients With Moderate To Severe Crohn's Disease
Medical News Today
Saturday, November 8, 2008 - 12:45pm
tags:
Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival As A First-Line Maintenance Therapy For Advanced Non-Small Cell Lung Cancer
Medical News Today
Saturday, November 8, 2008 - 12:44pm
tags:
FDA to decide on Discovery Labs drug in April 2009
Yahoo/AP
Saturday, November 8, 2008 - 12:43pm
tags:
The Time May Be Right for Investing in Medicine
New York Times
Saturday, November 8, 2008 - 12:36pm
tags:
Onyx licenses cancer compound from BTG International
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:33pm
tags:
Aegerion presents positive results from Phase II studies of dyslipidemia drug
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:32pm
tags:
Applied Biosystems and Asuragen form collaboration with C-Path
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:31pm
tags:
Spectrum Pharmaceuticals wins $41.5 million payment from Allergan
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:31pm
tags:
Genentech, OSI Pharmaceuticals report positive Phase III cancer study results
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:30pm
tags:
Daiichi Sankyo completes purchase of stake in Ranbaxy
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:28pm
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Crafting Effective, Patient-Centric Channel Strategies
Drug Channels
Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers
Drug Channels
Optimizing Product Commercialization in Today’s IDN Environment
Drug Channels
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating
Drug Channels
At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs
Drug Channels
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts
Drug Channels
Breaking Down Medication Access and Affordability Barriers
Drug Channels
Drug Channels News Roundup, June 2024: Cordavis Humira Update, OptumRx’s New Biosim Biz, Generic Drugs' Wild Ride, IRA Predictions, and Dr. G on Med School
Drug Channels
Meet the Four Executives Headlining the Drug Channels Leadership Forum
Drug Channels

Latest Jobs

Account Executive - Hospice
Freeman, Missouri, 64746
Agape Care Group
Account Executive - Hospice
Wellington, Missouri, 64097
Agape Care Group
Account Executive - Hospice
Napoleon, Missouri, 64074
Agape Care Group
Healthcare Sales Professional
Denton, Texas, Texas
Tris Pharma
Psychiatry Account Manager - Santa Monica, CA
Santa Monica, California
Lundbeck
Senior Account Consultant, Durysta - San Diego, CA
San Diego, California, California
AbbVie
Senior Account Consultant, Retina - Hartford, CT
New Haven, Connecticut, Connecticut
AbbVie
Oncology Specialist - New York City
New York City, New York
AbbVie
Associate Director, Strategic Account Manager, Southern California
Los Angeles, California, California
AbbVie
Oncology Specialist - LA West
Santa Monica, California
AbbVie
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information